10 May 2023>: Clinical Research
Surgical Outcomes in 62 Patients with Ulcerative Colitis: A Retrospective, Single-Center Study from Poland
Zofia Kampka 1BDEF* , Marek Zielonka 1ABD , Marta Kozikowska 1BEF , Grzegorz Wypych 1AB , Patryk Zemła 1CD , Beata Jabłońska 2ADE , Sławomir Mrowiec 2AFDOI: 10.12659/MSM.939412
Med Sci Monit 2023; 29:e939412
Table 1 Baseline characteristics.
n (%) orMean±SD | 95% lower bound CI, 95% upper bound CI | ||
---|---|---|---|
Male | 36 (58.1%) | ||
Female | 26 (41.9%) | ||
Age | 52.69±16.84 | 48.42, 56.97 | |
BMI [kg/m] | 23.10±5.50 | 21.45, 24.75 | |
Overweight | 8 (12.9%) | ||
Obesity | 5 (8.1%) | ||
Malnutrition | 13 (21.0%) | ||
Parenteral nutrition | 5 (8.1%) | ||
Comorbidities | Diabetes mellitus | 5 (8.1%) | |
Hypertension | 9 (14.5%) | ||
Other CVD | 11 (17.7%) | ||
Hypothyroidism | 2 (3.2%) | ||
Current smoker | 4 (6.5%) | ||
Anaemia | 17 (68.0%) | ||
Hypoalbuminemia | 12 (92.3%) | ||
Diagnosis | Ulcerative colitis, unspecified | 21 (34.4%) | |
Other ulcerative colitis | 13 (21.3%) | ||
Ulcerative ileocolitis | 10 (16.4%) | ||
Ulcerative rectosigmoiditis | 8 (13.1%) | ||
Ulcerative pancolitis | 4 (6.6%) | ||
Left sided colitis | 3 (4.9%) | ||
Inflammatory polyps of colon | 1 (1.6%) | ||
Ulcerative proctitis | 1 (1.6%) | ||
Time from diagnosis to surgery [years] | 5.68±6.04 | 3.5, 7.82 | |
Surgery length [hours] | 5.29±1.61 | 4.43, 6.15 | |
Total hospitalization time [days] | 17.46±11.55 | 14.18, 20.74 | |
Pharmacological treatment prior to surgery | 5-ASA | 33 (53.2%) | |
Mesalazine | 19 (30.6%) | ||
Sulfasalazine | 14 (22.6%) | ||
Glucocorticosteroids | 37 (59.7%) | ||
Biological therapy | 7 (11.3%) | ||
Immunosuppressive drugs | 24 (38.7%) | ||
Urgent surgery | 21 (36.2%) | ||
Elective surgery | 37 (63.8%) | ||
Postoperative complications | 25 (40.3%) | ||
Postoperative complications | Wound suppuration | 14 (22.6%) | |
Wound dehiscence | 6 (9.7%) | ||
Intra-abdominal hemorrhage | 4 (6.5%) | ||
Sepsis | 3 (4.8%) | ||
Anastomotic leaks | 1 (1.6%) | ||
Intestinal obstruction | 1 (1.6%) | ||
Relaparotomy | 14 (22.6%) | ||
Rehospitalization | 2 (3.2%) | ||
Mortality | 8 (12.9%) | ||
Data are presented as number and percentage (in brackets) of patients or mean±standard deviation (SD) and 95% confidence interval (CI) – lower and upper bound. BMI – body mass index; CVD – cardiovascular disease; 5-ASA – 5-aminosalicylic acid derivatives. |